A kind of enteromorpha polysaccharide compound auxiliary blood fat-lowering health care product and preparation method thereof

Abstract

An Enteromorpha prolifera polysaccharide composite blood lipid-lowering health care product. The health care product is a capsule or a tablet or a granule, and consists of the following raw materials: 50-70 parts of an Enteromorpha prolifera polysaccharide extract, 10-15 parts of a Puerariae radix extract, 5-10 parts of a Gynostemma pentaphylla extract, 5-10 parts of a hawthorn extract and 10-15 parts of a Monacolin-R, the parts of each raw material being all in parts by weight. Further provided is a preparation method for the health care product. The raw materials are mixed in the parts by weight mentioned above, shaped, dried, packaged and inspected to obtain a final product.

Description

technical field [0001] The invention belongs to the field of health care products, in particular to an enteromorpha polysaccharide compound auxiliary blood fat-lowering health care product and a preparation method thereof. Background technique [0002] Cardiovascular and cerebrovascular diseases are collectively referred to as cardiovascular and cerebrovascular diseases, and generally refer to diseases such as heart disease, cerebral thrombosis, and cerebral hemorrhage caused by hyperlipidemia, blood viscosity, atherosclerosis, and high blood pressure. The number of people who die from cardiovascular and cerebrovascular diseases is as high as 15 million every year in the world, ranking first among various causes of death. [0003] Hyperlipidemia is the culprit that induces repeated rises in blood pressure. The blood is thick and the blood flow is blocked. The blood can only pass through by squeezing the blood vessels by the force of the blood flow. The pressure on the blood...

AI Technical Summary

Problems solved by technology

In addition, this product was also informed by the staff of the Shandong Provincial Center for Disease Control and Prevention that the substrates of rats and human bodies are quite different, and clinical practice should be responsible for the lives of patients. It is cold, lotus leaf and tea are cool, only hawthorn is warm, and the effect of hawthorn's warmness and coolness is very limited, making the compound enteromorpha polysaccharide obviously too cold, which greatly stimulates the digestive system of the subjects. , with obvious side effects, therefore, it cannot be used in normal human trials

In addition, in fact, even if the products that have auxiliary blood lipid-lowering effect through animal tests are often used in clinical trials, they often do not have the auxiliary blood-lipid-lowering effect. As a test subject, the subject actually only has short-term hyperlipidemia, and the blood lipid index is easy to drop, but for a natural person with diabetes or hyperlipidemia, it is long-term hyperlipidemia, and the blood lipid index is not so easy to drop

[0008] Table 1. Effects of existing compound Enteromorpha polysaccharide products on blood lipids (mmol / L, n=10) in rats

Images